Education
About Us
Working with TipRanks
Follow Us
SpectraCure AB (SE:SPEC)
:SPEC
Photodynamic Therapy (Pdt), Verteporfin Injection
Prostate Cancer
Phase I/II
Recruiting
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
Jan 29, 2025
―
Verteporfin, Spectracure P18 System
Recurrent Prostate Cancer
Phase I/II
Recruiting
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
Feb 13, 2017
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does SpectraCure AB (SPEC) have in its pipeline
SPEC is currently developing the following drugs: Photodynamic Therapy (Pdt), Verteporfin Injection, Verteporfin, Spectracure P18 System. These drug candidates are in various stages of clinical development as the company works toward FDA approval.